These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35064903)

  • 21. Under-recognition of Low Blood Pressure Readings in Patients with Duchenne Muscular Dystrophy.
    Masood SA; Kazmouz S; Heydemann P; Li H; Kenny D
    Pediatr Cardiol; 2015 Oct; 36(7):1489-94. PubMed ID: 25981564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy.
    Bourke JP; Bueser T; Quinlivan R
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009068. PubMed ID: 30326162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Participation in daily life activities and its relationship to strength and functional measures in boys with Duchenne muscular dystrophy.
    Bendixen RM; Lott DJ; Senesac C; Mathur S; Vandenborne K
    Disabil Rehabil; 2014; 36(22):1918-23. PubMed ID: 24499260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytological and Cytomorphometric Study of Exfoliated Cells of the Oral Mucosa in Diabetic Patients.
    Gaddikeri K; Abidullah M; Bhorgonde D
    J Pharm Bioallied Sci; 2020 Aug; 12(Suppl 1):S86-S90. PubMed ID: 33149436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postcontractile blood oxygenation level-dependent (BOLD) response in Duchenne muscular dystrophy.
    Lopez C; Taivassalo T; Berru MG; Saavedra A; Rasmussen HC; Batra A; Arora H; Roetzheim AM; Walter GA; Vandenborne K; Forbes SC
    J Appl Physiol (1985); 2021 Jul; 131(1):83-94. PubMed ID: 34013753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
    Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
    EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gait deviations in Duchenne muscular dystrophy-Part 2. Statistical non-parametric mapping to analyze gait deviations in children with Duchenne muscular dystrophy.
    Goudriaan M; Van den Hauwe M; Simon-Martinez C; Huenaerts C; Molenaers G; Goemans N; Desloovere K
    Gait Posture; 2018 Jun; 63():159-164. PubMed ID: 29751322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Profoundly lower muscle mass and rate of contractile protein synthesis in boys with Duchenne muscular dystrophy.
    Evans WJ; Shankaran M; Smith EC; Morris C; Nyangau E; Bizieff A; Matthews M; Mohamed H; Hellerstein M
    J Physiol; 2021 Dec; 599(23):5215-5227. PubMed ID: 34569076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel mouse model of Duchenne muscular dystrophy carrying a multi-exonic
    Wong TWY; Ahmed A; Yang G; Maino E; Steiman S; Hyatt E; Chan P; Lindsay K; Wong N; Golebiowski D; Schneider J; Delgado-Olguín P; Ivakine EA; Cohn RD
    Dis Model Mech; 2020 Sep; 13(9):. PubMed ID: 32988972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of growth in ambulatory males with Duchenne muscular dystrophy.
    West NA; Yang ML; Weitzenkamp DA; Andrews J; Meaney FJ; Oleszek J; Miller LA; Matthews D; DiGuiseppi C
    J Pediatr; 2013 Dec; 163(6):1759-1763.e1. PubMed ID: 24103921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review.
    Gatheridge MA; Kwon JM; Mendell JM; Scheuerbrandt G; Moat SJ; Eyskens F; Rockman-Greenberg C; Drousiotou A; Griggs RC
    JAMA Neurol; 2016 Jan; 73(1):111-6. PubMed ID: 26594870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growing patients with Duchenne muscular dystrophy: longitudinal changes in their dentofacial morphology and orofacial functional capacities.
    Egli F; Botteron S; Morel C; Kiliaridis S
    Eur J Orthod; 2018 Apr; 40(2):140-148. PubMed ID: 28520860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytomorphometric analysis of gingival epithelium and buccal mucosa cells in type 2 diabetes mellitus patients.
    Sahu M; Suryawanshi H; Nayak S; Kumar P
    J Oral Maxillofac Pathol; 2017; 21(2):224-228. PubMed ID: 28932031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Causes of clinical variability in Duchenne and Becker muscular dystrophies and implications for exon skipping therapies.
    Hoffman EP
    Acta Myol; 2020 Dec; 39(4):179-186. PubMed ID: 33458572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-body clearing, staining and screening of calcium deposits in the mdx mouse model of Duchenne muscular dystrophy.
    Bozycki L; Łukasiewicz K; Matryba P; Pikula S
    Skelet Muscle; 2018 Jul; 8(1):21. PubMed ID: 30025544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aldehyde dehydrogenases contribute to skeletal muscle homeostasis in healthy, aging, and Duchenne muscular dystrophy patients.
    Etienne J; Joanne P; Catelain C; Riveron S; Bayer AC; Lafable J; Punzon I; Blot S; Agbulut O; Vilquin JT
    J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):1047-1069. PubMed ID: 32157826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Direct Cost of Managing a Rare Disease: Assessing Medical and Pharmacy Costs Associated with Duchenne Muscular Dystrophy in the United States.
    Thayer S; Bell C; McDonald CM
    J Manag Care Spec Pharm; 2017 Jun; 23(6):633-641. PubMed ID: 28530521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common therapeutic advances for Duchenne muscular dystrophy (DMD).
    Salmaninejad A; Jafari Abarghan Y; Bozorg Qomi S; Bayat H; Yousefi M; Azhdari S; Talebi S; Mojarrad M
    Int J Neurosci; 2021 Apr; 131(4):370-389. PubMed ID: 32241218
    [No Abstract]   [Full Text] [Related]  

  • 39. Inspiratory flow reserve in boys with Duchenne muscular dystrophy.
    De Bruin PF; Ueki J; Bush A; Y Manzur A; Watson A; Pride NB
    Pediatr Pulmonol; 2001 Jun; 31(6):451-7. PubMed ID: 11389578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. De novo revertant fiber formation and therapy testing in a 3D culture model of Duchenne muscular dystrophy skeletal muscle.
    Ebrahimi M; Lad H; Fusto A; Tiper Y; Datye A; Nguyen CT; Jacques E; Moyle LA; Nguyen T; Musgrave B; Chávez-Madero C; Bigot A; Chen C; Turner S; Stewart BA; Pegoraro E; Vitiello L; Gilbert PM
    Acta Biomater; 2021 Sep; 132():227-244. PubMed ID: 34048976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.